Goldman Sachs’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $16.1M | Buy |
|
|||||
|
2021
Q2 | $22.8M | Sell |
|
|||||
|
2021
Q1 | $27.3M | Sell |
|
|||||
|
2020
Q4 | $23.8M | Buy |
|
|||||
|
2020
Q3 | $12.6M | Buy |
|
|||||
|
2020
Q2 | $13.3M | Sell |
|
|||||
|
2020
Q1 | $22.1M | Buy |
|
|||||
|
2019
Q4 | $16.8M | Sell |
|
|||||
|
2019
Q3 | $11.2M | Sell |
|
|||||
|
2019
Q2 | $21M | Buy |
|
|||||
|
2019
Q1 | $16.3M | Sell |
|
|||||
|
2018
Q4 | $13.2M | Sell |
|
|||||
|
2018
Q3 | $20.7M | Buy |
|
|||||
|
2018
Q2 | $6.76M | Sell |
|
|||||
|
2018
Q1 | $7.54M | Buy |
|
|||||
|
2017
Q4 | $1.75M | Buy |
|
|||||
|
2017
Q3 | $606K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $70K | Sell |
|
|||||
|
2016
Q3 | $254K | Sell |
|
|||||
|
2016
Q2 | $130K | Buy |
|
|||||
|
2016
Q1 | $167K | Buy |
|
|||||
|
2015
Q4 | $188K | Buy |
|
|||||
|
2015
Q3 | $109K | Sell |
|
|||||
|
2015
Q2 | $330K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $256K | Buy |
|